multiple sclerosis therapeutic peptides (Viral Genetics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemultiple sclerosis therapeutic peptides (Viral Genetics)
Drug Alias NameTPT-based therapeutics (VG Life Sciences)TPT-based therapeutics (Viral Genetics)multiple sclerosis therapeutic peptides (VG Life Sciences)targeted peptide technology-based therapeutics (VG Life Sciences)targeted peptide technology-based therapeutics (Viral Genetics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVg Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVg Life Sciences
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A